Martin Than discusses his study group’s randomized trial comparing a 2-hour diagnostic protocol with a standard protocol for patients who report chest pain in the emergency department.
Michael S. Lauer discusses his article titled “The Randomized Registry Trial — The Next Disruptive Technology in Clinical Research?”
On the last afternoon at AHA.13, a poster on an experimental preventive treatment catches the eye of a cardiology Fellow .
A Fellow wonders about a “fabulous” presentation — why was it held at a relatively early hour and in one of the smaller meeting rooms?
A fellow describes his wish list for conferences that better meet the needs of trainees.
Several Cardiology Fellows who are attending AHA.13 in Dallas this week are blogging for CardioExchange. The Fellows include Vimal Ramjee, Siqin Ye, Seth Martin, Reva Balakrishnan, and Saurav Chatterjee. You can find the previous post here. For more of our AHA.13 coverage of late-breaking clinical trials, interviews with the authors of the most important research, and blogs from our fellows on…
TACT investigator Gervasio Lamas provides an inside look at how the TACT trial began, the controversial journey so far, and what he hopes it will accomplish.
This Fellow needs to leave AHA early and wonders what she is missing.
This cardiology fellow is stunned by some of the basic science reported at AHA.13.
A cardiology fellow at AHA gets advice from a more-established research clinician.